According to Acumen Research, “The global Anatomic Pathology Market is projected to reach USD 24 billion by 2026, growing with a CAGR between 6% from 2020 to 2026”. The market report provides an analysis of the global Anatomic Pathology Market for the period 2016-2026, wherein 2020 to 2026 is the forecast period and 2019 is considered as the base year.
Technology is expected to boost the adoption rate of sophisticated anatomical pathological devices in tools and protocols used during anatomical pathology. The integration of healthcare informatics norms by improving effectiveness and reducing expenses is a driving factor for the industry. Market actors cooperate in pathology laboratory renovation with the incorporation of innovative models for diagnosing diseases. This in turn speeds up investments in pathological machinery upgrading.
Thermo Fisher and Leica Microsystems worked together in April 2018 to develop an integrated workflow for studying cryo-tomography. Within the framework of this partnership, the businesses combined their current technology to provide improved microscopic alternatives that are user friendly and reliable, allowing scientists to obtain insights into biological procedures.
The anatomical pathology market is supported by pathology-trainee programs provided by government and private bodies to pathologists. Some of the associations which started various training programs and exams for the evaluation of a pathologist’s skill and understanding are the Royal College of Pathologists and the General Medical Council and the Association of Anatomical Pathology Technology.
Get FREE SAMPLE PDF (Including Full TOC, Table & Figures)@ https://www.acumenresearchandconsulting.com/request-sample/1525
The Diagnostics Laboratories segment is anticipated to achieve the fastest growth rate with technological developments in tools to minimize the danger of mistakes by integrating novel designs.
The dominant income share of the consumables has been ascribed to high availability, low costs and frequent buy rates of consumables such as reagents and samples.
The scholarly study sector has been driven by the increased application of anatomical pathology processes in studies like tumor examination and biomarker profiling.
The shift from standard to custom medicine has led to the fastest growth of the drug discovery and development sector. This is mainly because findings of alleged biomarkers are increasingly being relied upon to develop personalisation.
The biggest share of hospitals has been contributed by increasing hospitalization rates which stimulates the implementation of pathological workflows for disease monitoring and diagnosis.
On the other side, the development of the diagnostic lab segment is enhanced by the use of advanced laboratory devices and instruments, various electronic interfaces and IT systems.
In addition to a big amount of government financing programs, the presence of important players like Thermo Fisher and Agilent contributes to the biggest proportion in North America.
Asia Pacific is anticipated to show the highest development in the industry of anatomic pathology driven by the existence of numerous organizations involved in pathology practice.
The diagnosis of multiple infectious diseases, multiple cancer types as well as medical circumstances involves anatomical pathology by examining tissues and cells samples from the biopsy report. Increasingly aging, chronic illnesses are on the rise, and expensive healthcare are all showing favorable development in this industry. This has recently improved the need for the market for anatomic pathology. In the coming years, the nations with the highest amount of older populations will develop the market for anatomical pathology. Technological advances will also function as the driving force for this industry in the healthcare industry.
Key Players & Strategies
Some of the key players are Laboratory Corporation of America Holdings; Thermo Fisher Scientific, Inc.; Sakura Finetek USA, Inc.Cardinal Health, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Quest Diagnostics Incorporated; BioGenex; NeoGenomics Laboratories, Inc.; and Bio SB.
These main players implement various approaches in order to retain their important market share during the forecast period. Collaborative development, corporate development and product development are the strategies introduced.
For instance, in June 2018, Agilent Technologies introduced a range of probes, such as MALT1, MYC, BCL6, BCL2, CCND1, IGH, IGH / BCL2, IGH / MYC, and IGH /CCND1, for in situ hybridization. The launch of these products has improved the portfolio of the company and thus reinforced its place in the industry.
Market Segmentation as below:
Market, By Product and Service
- Reagents & Antibodies
- Probes & Kits
- Tissue processors
- Automatic Stainers
- Microtomes & Cryostat
Market, By Application
- Drug Discovery & Development
- Disease Diagnosis
Market, By End-use
- Diagnostic Laboratories
- Research Laboratories
Market By Geography
(Regional Output, Demand & Forecast by Countries)
- North America (USA and Canada)
- Europe (UK, Germany, France, Spain and Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea and Rest of Asia-Pacific)
- Latin America (Mexico, Brazil and Rest of Latin America)
- Middle East and Africa (GCC, South Africa and Rest of MEA).
FYI, You will get the latest updated report as per the COVID-19 impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.
Customized Requirements? Inquiry Before Buying? Please Email us at email@example.com | Single User License US$ 4500
Overview of the Impact of COVID-19 on this market:
The development of COVID-19 has carried the world to a stop. We comprehend that this health emergency has brought an unprecedented effect on businesses across ventures. However, this also will pass. Rising help from governments and a few organizations can help in the battle against this profoundly infectious sickness. There are a few industries that are battling and some are flourishing. In general, pretty much every segment is foreseen to be affected by the pandemic.
We are taking persistent efforts to enable your business to continue and develop during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across ventures to assist you to prepare for the future.
The report is readily available and can be dispatched immediately after payment confirmation.
The Final Report will cover the impact analysis of COVID-19, Download Full Study Report (Single User License US$ 4500)@ https://www.acumenresearchandconsulting.com/buy-now/0/1525
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Phone: +14079154157 | +14089009135